Wired UK  |  August 8, 2019

“It’s really going to come down to whether FDA thinks that letting the product on the market is probably going to turn out okay,” says Eric Lindblom, a former FDA tobacco control official now at Georgetown Law’s O’Neill Institute. “I think for sure [Juul] is doing this in Canada and the UK in order to get really strong research to say ‘this stops or drastically reduces youth use of our product’ as that’s the only thing FDA has expressed a concern about.”

Read the article here.